PMC:7534795 / 30888-30953
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T153","span":{"begin":36,"end":43},"obj":"Body_part"},{"id":"T154","span":{"begin":52,"end":59},"obj":"Body_part"}],"attributes":[{"id":"A153","pred":"fma_id","subj":"T153","obj":"http://purl.org/sig/ont/fma/fma82839"},{"id":"A154","pred":"fma_id","subj":"T154","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"• Evaluation of 28-day mortality in heparin and non-heparin users"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T227","span":{"begin":36,"end":43},"obj":"Chemical"},{"id":"T228","span":{"begin":52,"end":59},"obj":"Chemical"}],"attributes":[{"id":"A227","pred":"chebi_id","subj":"T227","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A228","pred":"chebi_id","subj":"T228","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":"• Evaluation of 28-day mortality in heparin and non-heparin users"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T216","span":{"begin":0,"end":65},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"• Evaluation of 28-day mortality in heparin and non-heparin users"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"971","span":{"begin":36,"end":43},"obj":"Chemical"},{"id":"972","span":{"begin":52,"end":59},"obj":"Chemical"},{"id":"989","span":{"begin":23,"end":32},"obj":"Disease"}],"attributes":[{"id":"A971","pred":"tao:has_database_id","subj":"971","obj":"MESH:D006493"},{"id":"A972","pred":"tao:has_database_id","subj":"972","obj":"MESH:D006493"},{"id":"A989","pred":"tao:has_database_id","subj":"989","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"• Evaluation of 28-day mortality in heparin and non-heparin users"}